Preparing for COVID-19 vaccine success
The next steps for COVID-19 vaccines, a BioCentury/Biokatalyst webinar
The European Commission and international organizations are working to create a purchasing pool for global allocation of COVID-19 vaccines, according to Nicole Lurie, strategic adviser to the CEO of CEPI.
Lurie discussed the purchasing pool on a webinar about COVID-19 vaccine development co-hosted by BioCentury and BioKatalyst in collaboration with Lonza Group Ltd. (SIX:LONN). The webinar also included an update on a COVID-19 vaccine from CanSino Biologics Inc. (HKEX:6185), Lonza’s plans for manufacturing an RNA vaccine from Moderna Inc. (NASDAQ:MRNA), and perspective from Vaccitech Ltd. on the AZD1222 (formerly ChAdOx1 nCoV-19)